going back on semaglutide JOURNEY *week 3* // Feeling amazing, into strength training + down 10 lbs! Guess I am going back
Description
Semaglutides current regulatory approvals, practice considerations, and cost-effectiveness compared to similar therapies are also considered
Amble earned a perfect score here, and it deserves every point
Neither is the weight loss
Engineering bimodal molecules that integrate GLP-1R agonism with specific pain-related mechanisms may offer innovative therapeutic options
June 2023: The American Society of Anesthesiologists released guidance recommending temporary discontinuation of GLP-1 receptor agonists before elective surgical procedures to minimize complication risks
